Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Humira(Cf) Pen(Adalimumab)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$4.33B

Medicare cost, 2024

Medicare drug plans spent $4.3 billion on Humira(Cf) Pen (adalimumab) in 2024, for 490,135 prescriptions and refills filled by 63,749 patients. It ranks 9th among all drugs by Medicare drug plan spending. At about $8,828 per prescription it is a high-cost drug. New York accounts for the most spending ($314.9 million, 7% of the total).

Medicare cost, 2024

$4.33B

-2.1% from 2023

Prescriptions

490K

$8,828.43 per claim

Patients

64K

23,305 prescribers

Total spending, 2024

$4.33B

$67,881.99 per patient

Questions and answers

How much does Medicare spend on Humira(Cf) Pen?

Medicare prescription drug plans paid $4.33B for Humira(Cf) Pen in 2024, for 490,135 prescriptions and refills to 63,749 patients (down 2.1% from 2023). The average cost per claim was $8,828.43.

Which state spends the most on Humira(Cf) Pen?

New York had the highest Medicare cost for Humira(Cf) Pen in 2024: $314.9M for 34,468 claims, followed by Texas ($304.3M).

Who prescribes Humira(Cf) Pen the most?

Anne Marie Holly, physician assistant in Rochester, NY, had the highest Medicare cost for Humira(Cf) Pen in 2024: 902 claims costing $8.4M.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Humira(Cf) Pen was $4.33B in 2024, after a high of $4.42B in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Humira(Cf) Pen, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Anne Marie Holly Rochester, NYPhysician Assistant902190$8.4M
Wilfredo A Villarrubia West Columbia, SCPhysician Assistant640132$5.7M
Amanda L Matthews San Antonio, TXPhysician Assistant688101$5.3M
Michael Babilonia Roman Mayaguez, PRInternal Medicine73468$5.1M
Bernard S Hojaili New Iberia, LAInternal Medicine42658$4.5M
Rajiv E Shah Winston Salem, NCOphthalmology59569$4.3M
Gretchen J Crawford Tucson, AZNurse Practitioner39282$3.7M
Elvin R Garcia McAllen, TXRheumatology39451$3.6M
Luis C Salayandia El Paso, TXRheumatology45056$3.6M
Kayvan Kamali Longview, TXRheumatology49569$3.4M
Ulker Tok Tucson, AZRheumatology37687$3.4M
Seleaina A Thomas Victorville, CANurse Practitioner45453$3.3M
Livia M Bermudez Fajardo, PRRheumatology46957$3.2M
David G Stainbrook Jr. Du Bois, PARheumatology32238$3.2M
Shriram A Lokare Peoria, ILRheumatology41455$3.1M
Jolanta Sobotka-Czarnecki Flint, MIRheumatology43147$3.1M
Ruth A Wilson Lagrange, INNurse Practitioner31544$3.0M
Jorge A Mundo Humacao, PRRheumatology43156$3.0M
Deya M Obaidat Indianapolis, INRheumatology35052$3.0M
Justina J Tseng Redding, CARheumatology29542$2.8M
Zaida Z Fuxench Lopez Bayamon, PRInternal Medicine27330$2.8M
Marlon J Navarro Eau Claire, WIRheumatology36141$2.8M
Carl M Gauthier Jr. Hammond, LARheumatology34841$2.8M
Ashrito K Dayal Charlotte, NCRheumatology33840$2.8M
Elizabeth Harding Charleston, SCPhysician Assistant14419$2.7M

Prescriber data by year

YearPrescribersClaimsPatientsCost
202221,439438,15157,400$3.69B
202322,806478,67561,455$4.42B
202423,305490,13563,749$4.33B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Abbvie US LLCABBV logoABBV457,856$4.03B
Cordavis LimiteCVS logoCVS32,447$296.6M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube